ISRCTN22187559
Active, not recruiting
未知
Implementation of mailed (faecal immunochemical test) FIT outreach
Minneapolis VA Health Care System0 sites9,000 target enrollmentJanuary 8, 2024
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Minneapolis VA Health Care System
- Enrollment
- 9000
- Status
- Active, not recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Is not deceased
- •2\. Is a Veteran
- •3\. Must have deliverable address
- •4\. Active or pending primary care provider assignment
Exclusion Criteria
- •1\. Exclude patients from Northern Mariana Islands, Armed Forces Pacific, Palau, Virgin Islands, American Somoa, Armed Forces AF, EU, ME, CA, Puerto Rico, or any foreign country
- •2\. CAN score with 1 year mortality rate of \>50%
- •3\. Have received hospice care in the last two years
- •4\. Have received palliative care in the last year
- •5\. Have had ulcerative colitis diagnosis in the last year
- •6\. Have had crohn disease diagnosis in the last year
- •7\. History of adeoma in the last year
- •8\. Have had metastatic cancer diagnosis in the last year
- •9\. Any total colectomy procedures in the last year
- •10\. Frailty and advanced illness diagnosis in the last year
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Fecal Immunochemical Testing as a Tool to Determine the Need for Colonoscopy in Symptomatic PatientsColorectal cancerNL-OMON20343Erasmus MC (s-Gravendijkwal 230 3015 CE Rotterdam P.O. Box 2040, 3000 CA Rotterdam Phone: +31 10 704 0704) and Sysmex Europe (Postbus 251 4870 AG Etten-Leur Phone: +31(0)765086000)807
Completed
Not Applicable
Mailed Reminders Plus Fecal Immunochemical TestingColorectal Cancer ScreeningColorectal CancerNCT03176082UNC Lineberger Comprehensive Cancer Center2,144
Recruiting
Not Applicable
Development of a new immunochemistry method using antibodies of proteins related pancreatic cancer in the pancreatic cancer cellNeoplasmsKCT0004515Yonsei University Health System, Gangnam Severance Hospital100
Recruiting
Not Applicable
Development of a new immunochemistry method using antibodies of proteins related bile duct cancer in the bile duct cancer cell; pilot studyNeoplasmsKCT0003285Yonsei University Health System, Gangnam Severance Hospital100
Completed
Not Applicable
ELISPOT assay using induced sputumCertain infectious and parasitic diseasesKCT0000376Pusan National University Yangsan Hospital40